A randomized, open-label, multicenter study of liposomal amikacin for inhalation in adult patients with nontuberculous mycobacteria (NTM) lung infections caused by mycobacterium avium complex (MAC)
David E. Griffith (Tyler, United States of America), David Griffith, Patrick Flume, Kevin Winthrop, Rachel Thomson, Dirk Wagner, Jakko Van Ingen, Liza Micioni, John P. McGinnis II, Carlos Fernandez, Gina Eagle
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Disease area: Airway diseases, Respiratory infections
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: